Lemaitre Vascular Inc. (LMAT)
NASDAQ · Healthcare
Lemaitre Vascular Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 249.6M | 219.9M | 193.5M | 161.7M | 154.4M | 129.4M |
| Gross Profit | 178.5M | 150.9M | 127.0M | 104.9M | 101.4M | 84.6M |
| Profitability | ||||||
| Operating Income | 67.9M | 52.3M | 37.2M | 29.9M | 36.4M | 28.3M |
| EBITDA | 77.7M | 66.8M | 49.5M | 40.0M | 47.6M | 36.6M |
| Net Income | 57.7M | 44.0M | 30.1M | 20.6M | 26.9M | 21.2M |
| Per Share Data | ||||||
| EPS (diluted) | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 |
| Shares Outstanding (dil.) | 23M | 22M | 22M | 22M | 21M | 20M |
Lemaitre Vascular Inc. Income Statement — FAQ
Lemaitre Vascular Inc. (LMAT) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LMAT's income statement history?
The chart and table above show Lemaitre Vascular Inc.'s income statement by year and by quarter, including the growth rate.